Grateful for the pivotal first funding support for #RenalMedullaryCarcinoma by Conquer Cancer, the ASCO Foundation & Kidney Cancer MD Anderson Cancer Center. It takes a village for progress in #RareCancers & appreciative of trailblazing efforts by NCI Urologic Oncology Branch Mark Ball, MD, FACS across #kidneycancer subtypes.

Excited to publish Harvard Data Science Review an overview on interpreting randomized controlled trials focusing on information. By prioritizing this fundamental principle, previously obscure statistical concepts reveal their intrinsic beauty: hdsr.mitpress.mit.edu/pub/yb9eq8ja/r…

Research, teamwork, determination, and patient advocacy can transform the “impossible” into reality. #RenalMedullaryCarcinoma #endRMC #RareCancers #KidneyCancer Heather Williams Katie Coleman Bora Lim, MD Chad Tang, MD Giannicola Genovese MD, PhD Luigi Perelli RMC Alliance Chris Johnson Foundation Inc. R.M.C. Inc

Pleasure working with Aaron Seo and looking forward to this next year with Linghua Wang, MD, PhD and Pavlos Msaouel. Excited to get more rad onc trainees from MD Anderson Cancer Center interested in Kidney Cancer, which they don’t even have a single lecture about in their entire training😝.

At #ASCO24, our resident Dr. Aaron Seo shares results from a comparison of tissue sources for ctDNA assays in clear cell renal cell carcinoma. Aaron Seo ASCO #EndCancer

(1/5) Tweetorial for our phase II, investigator-initiated trial of 6 months, pre-operative apalutamide monotherapy for men with localized IRPCa led by John W. Davis, MD and the MD Anderson Cancer Center Uro Onc team shorturl.at/k60s4 in BJU International

Sunday… Costco’ed too hard.

1/5 Excited to share our @MsaouelLab clinical analysis of 135 patients with #RenalMedullaryCarcinoma treated MD Anderson Cancer Center over 20 years 👉sciencedirect.com/science/articl… #endRMC #rarecancers Kidney Cancer Chris Johnson Foundation Inc. RMC Alliance R.M.C. Inc Rare Cancer Research Foundation + Pattern.org The Renal Medullary Carcinoma Research Foundation KCCure

Of all the milestones our research MD Anderson Cancer Center has accomplished for #RenalMedullaryCarcinoma, this is definitely a favorite. Grateful to the many people who work tirelessly to help our patients. youtu.be/i4haAi8s0Ns #kidneycancer #MsaouelLab Bora Lim, MD

Dr. Ethan Ludmir, along with Dr. Chad Tang, shares why findings from a recent trial suggest a new treatment approach "potentially represents a paradigm shift in treating metastatic pancreatic cancer.” Read more: bit.ly/3WzgSjp Ethan Ludmir MD Chad Tang, MD #PancreaticCancer

Proud of Pradeep Chauhan (lead scientist) + PhD student Irfan +undergrad Savar for our latest ctDNA paper Clinical Cancer Research on met prostate cancer! aacrjournals.org/clincancerres/… Mayo Clinic Radiation Oncology Mayo Clinic Comprehensive Cancer Center Mayo Clinic Caltech Student-Faculty Programs WashUOncology Tulane Medicine Oliver J. Sartor Russell Pachynski Christopher Maher

Happy to announce that the PEACE 6 OligoPRESTO trial testing the role of metastasis directed therapy in hormone sensitive #ProstateCancer has completed accrual ahead of schedule. 550 patients randomized. Waiting now for data to mature.

Calling all #RLT fans. Amazing data presented by silke gillessen bringing back an oldie but a goodie. Large phase 3 PEACE3 results showing OS benefit with #radium223 without significant increase in toxicity in the frontline mCRPC setting.

Pleasure meeting Enrique. After years talking over zoom I find out he’s a real person.

Thanks Sumanta K. Pal, MD, FASCO for highlight the session. The title given to me for this topic was “Is there a role of radiation for advanced RCC?”. I hope was able to convey that my answer is an enthusiastic YES!